Thank you, Madam Chair.
Thank you to all the witnesses for being here.
I think it is so profoundly important that we conclude our study on diabetes by hearing from patients and people who deal on the front lines with patients. We've heard a lot of academic and interesting policy information on diabetes, but you're bringing home to this committee in the most powerful way possible what we need to hear as policy-makers to address this chronic, widespread and, frankly, growing problem.
Ms. Kyle, I want to start with you and pick up on something I heard you say. You don't view diabetes as a disability. We know that individuals with type 1 and type 2 diabetes can face diabetes-related stigma. I'm curious what your comments might be on that, because I think that may have emerged from your very clear statement.